Covestor
IONS icon

Covestor’s Ionis Pharmaceuticals IONS Stock Holding History

Covestor’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9K Buy
202
+6
+3% +$341 0.01% 1554
2026
Q2 		$16K Buy
196
+14
+8% +$1.05K 0.01% 1272
2026
Q1 		$14K Sell
182
-91
-33% -$7.18K 0.01% 1259
2025
Q4 		$22K Buy
273
+27
+11% +$2.03K 0.01% 1251
2025
Q3 		$16K Sell
246
-59
-19% -$2.88K 0.01% 1365
2025
Q2 		$12K Buy
305
+7
+2% +$229 0.01% 1474
2025
Q1 		$9K Buy
298
+52
+21% +$1.7K 0.01% 1559
2024
Q4 		$9K Sell
246
-4
-2% -$150 0.01% 1595
2024
Q3 		$10K Buy
250
+7
+3% +$326 0.01% 1562
2024
Q2 		$12K Buy
243
+1
+0.4% +$41 0.01% 1412
2024
Q1 		$11K Sell
242
-1
-0.4% -$48 0.01% 1514
2023
Q4 		$12K Hold
243
– – 0.01% 1428
2023
Q3 		$11K Sell
243
-3
-1% -$124 0.01% 1379
2023
Q2 		$10K Sell
246
-2
-0.8% -$77 0.01% 1435
2023
Q1 		$9K Buy
248
+2
+0.8% +$75 0.01% 1366
2022
Q4 		$9K Sell
246
-11
-4% -$463 0.01% 1370
2022
Q3 		$11K Sell
257
-109
-30% -$4.59K 0.01% 1225
2022
Q2 		$14K Sell
366
-11
-3% -$415 0.01% 1087
2022
Q1 		$14K Buy
377
+345
+1,078% +$11.3K 0.01% 1188
2021
Q4 		$1K Buy
+32
New +$1.01K ﹤0.01% 1789

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

Covestor's IONS Position: Q3 2026 in Review

Covestor increased its Ionis Pharmaceuticals (IONS) stake by 3.1% in Q3 2026, buying an estimated $341 and bringing the position to 202 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1554.

Covestor first reported a position in IONS in Q4 2021 and has held it in 20 quarters since. The position peaked at $22K in Q4 2025. 177 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Covestor held 202 shares of Ionis Pharmaceuticals worth $9K as of Q3 2026.
  • Covestor bought 6 Ionis Pharmaceuticals shares in Q3 2026, an estimated $341.
  • Ionis Pharmaceuticals made up 0.01% of Covestor's portfolio in Q3 2026, its #1554 holding.
  • Covestor first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Ionis Pharmaceuticals position peaked at $22K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.